Maury Raycroft
Stock Analyst at Jefferies
(1.50)
# 3,425
Out of 5,182 analysts
59
Total ratings
31.11%
Success rate
-4.74%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $39.61 | +8.56% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $86.00 | -5.81% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $22.45 | +180.62% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.32 | +56.25% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $112.63 | +18.97% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $15.61 | +34.53% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.14 | +40.35% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $318.85 | +72.18% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $7.40 | -5.41% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $40.63 | -63.08% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.58 | +121.52% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $10.17 | +421.14% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.45 | +46.79% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.30 | +899.67% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $17.81 | -66.31% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $21.63 | -12.16% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $3.32 | +351.81% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.18 | +3,235.19% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.35 | +1,603.70% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $1.59 | +12,164.15% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $9.02 | +21.95% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $40.86 | -85.32% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $61.03 | +22.89% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.12 | +252.56% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.73 | +189.86% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $6.10 | +490.16% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $7.49 | +1,301.87% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $49.51 | +247.40% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.39 | +1,866.53% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $13.13 | +219.88% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $39.61
Upside: +8.56%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $86.00
Upside: -5.81%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $22.45
Upside: +180.62%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.32
Upside: +56.25%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $112.63
Upside: +18.97%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $15.61
Upside: +34.53%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.14
Upside: +40.35%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $318.85
Upside: +72.18%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $7.40
Upside: -5.41%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $40.63
Upside: -63.08%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.58
Upside: +121.52%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $10.17
Upside: +421.14%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.45
Upside: +46.79%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.30
Upside: +899.67%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $17.81
Upside: -66.31%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $21.63
Upside: -12.16%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $3.32
Upside: +351.81%
Mar 13, 2024
Initiates: Buy
Price Target: $6
Current: $0.18
Upside: +3,235.19%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.35
Upside: +1,603.70%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $1.59
Upside: +12,164.15%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $9.02
Upside: +21.95%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $40.86
Upside: -85.32%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $61.03
Upside: +22.89%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.12
Upside: +252.56%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.73
Upside: +189.86%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $6.10
Upside: +490.16%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $7.49
Upside: +1,301.87%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $49.51
Upside: +247.40%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.39
Upside: +1,866.53%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $13.13
Upside: +219.88%